You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 40 No. 10, October 1983 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (85)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Effect of Buspirone on Prolactin and Growth Hormone Secretion in Man

Herbert Y. Meltzer, MD; Rachel Flemming, PhD; Alan Robertson, MD

Arch Gen Psychiatry. 1983;40(10):1099-1102.


Abstract



• Buspirone hydrochloride, a compound with novel chemical structure, has been reported to be anxiolytic in man. Its mechanism of action as an anxiolytic is unknown, but preclinical studies have shown that it produces effects consistent with both a dopamine agonist and antagonist. In man, buspirone hydrochloride at doses of 30,60, and 90 mg orally significantly elevated plasma prolactin (PRL) and growth hormone (GH) concentrations. The apparent increase in PRL secretion was dose dependent, but that of GH was not. The increase in PRL secretion could be due to a dopamine antagonist effect at the pituitary gland. A dopamine agonist action at hypothalamic dopamine receptors could account for the increase in GH secretion. Benzodiazepine anxiolytic drugs also increase serum GH levels in man, by a mechanism that has not been clearly established. It may be that buspirone and benzodiazepine drugs stimulate GH secretion by a common mechanism that is related to their anxiolytic actions.



Author Affiliations



From the Department of Psychiatry, University of Chicago, Pritzker School of Medicine (Drs Meltzer and Robertson), and the Illinois State Psychiatric Institute (Drs Meltzer, Flemming, and Robertson), Chicago.


Footnotes



Accepted for publication Oct 5, 1982.

Reprint requests to University of Chicago, Pritzker School of Medicine, 950 E 59th St, Chicago, IL 60637 (Dr Meltzer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Menstrual cycle effects on the action of buspirone on food intake in healthy female volunteers
Goodall et al.
J Psychopharmacol 1995;9:307-312.
ABSTRACT  

BAP/SKB Young Psychopharmacologist Award Towards a neuroendocrinology of obsessive-compulsive disorder
Lucey
J Psychopharmacol 1994;8:250-257.
ABSTRACT  

Acute exacerbation of psychosis with buspirone?
Pantelis and Barnes
J Psychopharmacol 1993;7:295-300.
ABSTRACT  

Prolactin and Cortisol Responses to MK-212, a Serotonin Agonist, in Obsessive-Compulsive Disorder
Bastani et al.
Arch Gen Psychiatry 1990;47:833-839.
ABSTRACT  

Preliminary Evidence of a Serotonin (5-HT-1-Like) Component to the Prolactin Response to Buspirone Challenge in Humans
Coccaro et al.
Arch Gen Psychiatry 1990;47:594-595.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.